Iomazenil

also known as Iomazenil, i-123 · RO 16-0154

today NCT01590277 · Ph 1

201320142015201620172018201920202021202220232024202520262027

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 1	NCT01590277	Dec 2012 → Nov 2018	alcohol-induced mental disorder	VA Office of Research and Development	Completed	No outcome recorded

Also used as a comparator or background therapy in 2 trials

Phase	Registry id	Dates	Indication	Sponsor	Status	Outcome
Phase 01 trial
Phase 0	NCT00982982 Comparator	Feb 2009 → Feb 2013	schizophrenia	Yale University	Completed	No outcome recorded
Phase 11 trial
Phase 1	NCT00611572 Comparator	Jan 2007 → Oct 2018	cognitive disorder	Yale University	Completed	No outcome recorded

Every value below carries the sentence it was read from. 4 sources stand behind the page.

Field	Value	Cited text
Known as	iomazenil	“This project is looking at the substance iomazenil and its effect on alcohol intoxication and alcohol's effects on driving using a driving simulator.” NCT01590277 ↗ 3 NCT01590277 ↗ NCT00982982 ↗ NCT00611572 ↗
Known as	Iomazenil, i-123	ChEMBL registry synonym — accepted as the source's own label CHEMBL2110679 ↗
Known as	RO 16-0154	ChEMBL registry synonym — accepted as the source's own label CHEMBL2110679 ↗
Modality	Small molecule	“benzodiazepine partial inverse agonist” NCT01590277 ↗
Route	Intravenous	“Given as IV infusion” NCT00611572 ↗